BGran® Synthetic Osteoconductive Scaffold
- Primary DI
- 07640151087517
- Brand
- BGran® Synthetic Osteoconductive Scaffold
- Company
- SpineArt SA
- Model
- BGS-010
- Catalog number
- BGS-010
- Device description
- Synthetic osteoconductive Scaffold_Volume 10cc
- Published
- 2017-09-18
- Public version status
- Update
- Distribution status
- In Commercial Distribution
- MRI safety
- Labeling does not contain MRI Safety Information
- Rx
- true
- Sterile
- true
- Single use
- true
Product Codes#
| Code | Name |
|---|---|
| MQV | Filler, Bone Void, Calcium Compound |
Product Code Classifications#
| Code | Device | Specialty | Class |
|---|---|---|---|
| MQV | Filler, Bone Void, Calcium Compound | Orthopedic | 2 |
Premarket Submissions#
| Submission | Supplement |
|---|---|
| K041616 | 000 |
Premarket Details#
Identifiers And Packaging#
| Identifier | Type | Agency | Package quantity | Status |
|---|---|---|---|---|
| 07640151087517 | Primary | GS1 | 0 |
Alternate GTIN / UPC / EAN Codes
| Source identifier | GTIN-14 normalized | EAN-13 |
|---|---|---|
| 07640151087517 | 07640151087517 | 7640151087517 |
GMDN Terms#
| Term | Definition |
|---|---|
| Bone matrix implant, synthetic | A sterile bioabsorbable device made of synthetic material intended to be implanted into the body to provide osteoconductive bone-tissue scaffolds, and sometimes osteovascularization, to replace bone lost through trauma, surgery, or pathological conditions (e.g., osteoporosis). It may be made of ceramics (e.g., tricalcium phosphate or hydroxyapatite), bioactive glasses/minerals/metals (e.g., strontium), or bioabsorbable polymers. It is used to fill cystic defects, repair fractures, and/or extend autogenous bone grafts and is typically provided as cancellous blocks, chips, or granules of varying sizes, or mouldable/fluid materials. |
Storage And Handling#
| Type | Low | High | Condition |
|---|---|---|---|
| Storage Environment Temperature | 10 Degrees Celsius | 30 Degrees Celsius |
Sterilization Methods#
| Method |
|---|
Regulatory Flags#
- DUNS number
- 483016148
- Device count
- 1
- Lot or batch
- true
- Manufacturing date on label
- true
- Expiration date on label
- true
Other Devices From This Company#
| Primary DI | Brand | Model | Catalog | Published |
|---|---|---|---|---|
| 07640221373021 | PERLA NAV | NAV-IN 11 50-N | NAV-IN 11 50-N | 2026-05-07 |
| 07640221373038 | PERLA ® TL | HAN-FI BA 50-N | 2026-05-07 | |
| 07640221373045 | PERLA ® TL | TLF-IN 01 60-N | 2026-05-07 | |
| 07640221373052 | PERLA NAV | NAV-IN 43 30-N | NAV-IN 43 30-N | 2026-05-07 |
| 07640221373069 | PERLA NAV | NAV-IN 43 60-N | NAV-IN 43 60-N | 2026-05-07 |
| 07640221373076 | PERLA ® TL | TLF-IN 03 70-N | 2026-05-07 | |
| 07640221373083 | PERLA ® TL | TLF-IN 12 00-N | 2026-05-07 | |
| 07640221373090 | PERLA ® TL | TLF-IN 04 70-N | 2026-05-07 | |
| 07640221373113 | PERLA NAV | NAV-IN 41 75-N | NAV-IN 41 75-N | 2026-05-07 |
| 07640221373120 | PERLA NAV | NAV-IN 41 80-N | NAV-IN 41 80-N | 2026-05-07 |
| 07640221373137 | PERLA NAV | NAV-IN 41 85-N | NAV-IN 41 85-N | 2026-05-07 |
| 07640221373144 | PERLA NAV | NAV-IN 41 90-N | NAV-IN 41 90-N | 2026-05-07 |
| 07640221373151 | PERLA NAV | NAV-IN 41 95-N | NAV-IN 41 95-N | 2026-05-07 |
| 07640221373168 | PERLA NAV | NAV-IN 41 00-N | NAV-IN 41 00-N | 2026-05-07 |
| 07640221373175 | PERLA NAV | NAV-IN 41 05-N | NAV-IN 41 05-N | 2026-05-07 |
| 07640221373182 | PERLA NAV | NAV-IN 41 10-N | NAV-IN 41 10-N | 2026-05-07 |
| 07640221373199 | PERLA NAV | NAV-IN 41 15-N | NAV-IN 41 15-N | 2026-05-07 |
| 07640221373205 | PERLA NAV | NAV-IN 41 20-N | NAV-IN 41 20-N | 2026-05-07 |
| 07640221373212 | PERLA NAV | NAV-IN 41 25-N | NAV-IN 41 25-N | 2026-05-07 |
| 07640221373229 | PERLA NAV | NAV-IN 42 70-N | NAV-IN 42 70-N | 2026-05-07 |
Other Devices Sharing Product Codes#
| Primary DI | Brand | Company | Product code | Published |
|---|---|---|---|---|
| W4184058150T0474 | DBX® | Musculoskeletal Transplant Foundation, Inc. | MQV | 2026-06-05 |
| 07610221017829 | Device 300423 Granules | Geistlich Pharma AG | MQV | 2026-06-01 |
| 07610221017836 | Device 300423 Granules | Geistlich Pharma AG | MQV | 2026-06-01 |
| 07610221017843 | Device 300423 Granules | Geistlich Pharma AG | MQV | 2026-06-01 |
| 07610221017850 | Device 300423 Granules | Geistlich Pharma AG | MQV | 2026-06-01 |
| 07610221017867 | Device 300423 Granules | Geistlich Pharma AG | MQV | 2026-06-01 |
| 07610221017874 | Device 300423 Granules | Geistlich Pharma AG | MQV | 2026-06-01 |
| 07610221017881 | Device 300423 Granules | Geistlich Pharma AG | MQV | 2026-06-01 |
| 07610221017898 | Device 300423 Granules | Geistlich Pharma AG | MQV | 2026-06-01 |
| 07610221017904 | Device 300423 Granules | Geistlich Pharma AG | MQV | 2026-06-01 |
| 07610221017911 | Device 300423 Granules | Geistlich Pharma AG | MQV | 2026-06-01 |
| 07610221017928 | Device 300423 Granules | Geistlich Pharma AG | MQV | 2026-06-01 |
| 03760191133723 | GlassBone Granules | NORAKER | MQV | 2026-05-27 |
| 03760191133730 | GlassBone Granules | NORAKER | MQV | 2026-05-27 |
| 03760191133747 | GlassBone Granules | NORAKER | MQV | 2026-05-27 |
| 03760191133754 | GlassBone Granules | NORAKER | MQV | 2026-05-27 |
| 03760191133761 | GlassBone Granules | NORAKER | MQV | 2026-05-27 |
| 03760191133778 | GlassBone Granules | NORAKER | MQV | 2026-05-27 |
| 03760191133785 | GlassBone Granules | NORAKER | MQV | 2026-05-27 |
| 03760191134812 | AktiBone Granules | NORAKER | MQV | 2026-05-27 |
| 03760191134829 | AktiBone Granules | NORAKER | MQV | 2026-05-27 |
| 03760191134836 | AktiBone Granules | NORAKER | MQV | 2026-05-27 |
| 03760191134843 | AktiBone Granules | NORAKER | MQV | 2026-05-27 |
| 03760191134850 | AktiBone Granules | NORAKER | MQV | 2026-05-27 |
| 03760191134867 | AktiBone Granules | NORAKER | MQV | 2026-05-27 |
| 03760191134874 | AktiBone Granules | NORAKER | MQV | 2026-05-27 |
| 03760191134881 | MectaBlast Granules | NORAKER | MQV | 2026-05-27 |
| 03760191134898 | MectaBlast Granules | NORAKER | MQV | 2026-05-27 |
| 03760191134904 | MectaBlast Granules | NORAKER | MQV | 2026-05-27 |
| 03760191134911 | MectaBlast Granules | NORAKER | MQV | 2026-05-27 |